RCAG
KYNB

Rehmann Capital Advisory Group’s Kyntra Bio KYNB Stock Holding History

Rehmann Capital Advisory Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.44K Hold
2
– – ﹤0.01% 1481
2019
Q2 		$1.76K Hold
2
– – ﹤0.01% 1809
2019
Q1 		$2.12K Buy
+2
New +$2.71K ﹤0.01% 1751
2018
Q3 		– Sell
-1
Closed -$1.19K – 2150
2018
Q2 		$1.19K Buy
+1
New +$1.3K ﹤0.01% 1927

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Rehmann Capital Advisory Group's KYNB Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Kyntra Bio (KYNB) position steady in Q3 2019 at 2 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Rehmann Capital Advisory Group first reported a position in KYNB in Q2 2018 and has held it in 4 quarters since. The position peaked at $2.12K in Q1 2019. 210 funds tracked by Wall St. Rank hold KYNB as of Q3 2019.

  • Rehmann Capital Advisory Group held 2 shares of Kyntra Bio worth $1.44K as of Q3 2019.
  • Rehmann Capital Advisory Group left its Kyntra Bio share count unchanged in Q3 2019.
  • Kyntra Bio made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1481 holding.
  • Rehmann Capital Advisory Group first reported a position in Kyntra Bio in Q2 2018 and has held it in 4 quarters since.
  • Rehmann Capital Advisory Group's Kyntra Bio position peaked at $2.12K in Q1 2019.
  • 210 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.